[go: up one dir, main page]

TR201100148A2 - Stable acarbose formulations. - Google Patents

Stable acarbose formulations.

Info

Publication number
TR201100148A2
TR201100148A2 TR2011/00148A TR201100148A TR201100148A2 TR 201100148 A2 TR201100148 A2 TR 201100148A2 TR 2011/00148 A TR2011/00148 A TR 2011/00148A TR 201100148 A TR201100148 A TR 201100148A TR 201100148 A2 TR201100148 A2 TR 201100148A2
Authority
TR
Turkey
Prior art keywords
acarbose
formulations
stable
adiposity
hyperlipidemia
Prior art date
Application number
TR2011/00148A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Bi̇lgi̇ç Mahmut
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bi̇lgi̇ç Mahmut filed Critical Bi̇lgi̇ç Mahmut
Priority to TR2011/00148A priority Critical patent/TR201100148A2/en
Priority to PCT/TR2012/000004 priority patent/WO2012093973A2/en
Publication of TR201100148A2 publication Critical patent/TR201100148A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş stabilite sorunu giderilmiş, akarboz içeren formülasyonlara ve bu formülasyonların diyabet, adipozite ve hiperlipidemide kullanımına yöneliktir.The present invention is directed to stabilized, acarbose-containing formulations and their use in diabetes, adiposity and hyperlipidemia.

TR2011/00148A 2011-01-06 2011-01-06 Stable acarbose formulations. TR201100148A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TR2011/00148A TR201100148A2 (en) 2011-01-06 2011-01-06 Stable acarbose formulations.
PCT/TR2012/000004 WO2012093973A2 (en) 2011-01-06 2012-01-06 Stable acarbose formulations

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2011/00148A TR201100148A2 (en) 2011-01-06 2011-01-06 Stable acarbose formulations.

Publications (1)

Publication Number Publication Date
TR201100148A2 true TR201100148A2 (en) 2012-07-23

Family

ID=45879005

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2011/00148A TR201100148A2 (en) 2011-01-06 2011-01-06 Stable acarbose formulations.

Country Status (2)

Country Link
TR (1) TR201100148A2 (en)
WO (1) WO2012093973A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014036528A2 (en) 2012-08-31 2014-03-06 Ixchel Pharma, Llc Agents useful for treating obesity, diabetes and related disorders
EP3943076A3 (en) * 2014-12-17 2022-04-13 Empros Pharma AB A modified release composition of orlistat and acarbose for the treatment of obesity and related metabolic disorders
CN104971080B (en) * 2015-06-09 2018-12-28 中国科学院西北高原生物研究所 Yellow bur reality polysaccharide improves the purposes of disorders of lipid metabolism
CN104983771B (en) * 2015-06-09 2018-12-28 中国科学院西北高原生物研究所 Yellow bur improves the purposes of disorders of lipid metabolism in fact
CN114053234A (en) * 2021-12-29 2022-02-18 江苏省药物研究所有限公司 Acarbose tablet and preparation method thereof
CN116650430A (en) * 2023-07-18 2023-08-29 浙江乐普制药有限公司 Acarbose tablet and preparation method thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2347782C3 (en) 1973-09-22 1979-10-11 Bayer Ag, 5090 Leverkusen Amino sugar derivatives, processes for their preparation and medicaments containing these compounds
DE3134591A1 (en) * 1981-09-01 1983-03-10 Bayer Ag, 5090 Leverkusen NEW MEDICINE PREPARATIONS FOR GLYCOSIDE HYDROLASE INHIBITORS
JPH0739340A (en) 1993-08-04 1995-02-10 Shozo Shimizu Method for preventing discoloration of foliage of japanese horseradish due to high-temperature heat sterilization
CA2128044C (en) * 1993-08-05 2007-02-20 Klaus-Dieter Bremer Pharmaceutical compositions comprising a glucosidase and/or amylase inhibitor, and a lipase inhibitor
US20040081697A1 (en) * 1998-11-12 2004-04-29 Smithkline Beecham P.L.C. Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent
FR2834214B1 (en) * 2001-12-28 2004-09-24 Lipha PHARMACEUTICAL COMPOSITION COMPRISING AN ALPHA-GLUCOSIDASE INHIBITOR AND 4-OXO-BUTANOIC ACID AND ITS USE FOR TREATING DIABETES
CN100464754C (en) * 2007-03-12 2009-03-04 杭州中美华东制药有限公司 Acarbose medicine composition and its prepn

Also Published As

Publication number Publication date
WO2012093973A3 (en) 2012-10-18
WO2012093973A2 (en) 2012-07-12

Similar Documents

Publication Publication Date Title
IL280949B (en) Ph20 polypeptide variants, formulations and uses thereof
IL282198A (en) Preparations containing active mitochondria and their uses
IN2015DN03029A (en)
UA114087C2 (en) HOLIDAYS
IL230662A0 (en) Indazole-type substances, preparations containing these substances and their uses
BR112015012907A2 (en) personal care composition
UY34350A (en) DERIVATIVES OF PIRAZOLQUINOLINONA, ITS PREPARATION AND THERAPEUTIC USE.
EA201270619A1 (en) USE OF BETANEHOL FOR THE TREATMENT OF XEROSTOMY
BR112013010834A2 (en) modified factor ix polypeptides and uses thereof
DK4374878T3 (en) PHARMACEUTICAL COMPOSITION COMPRISING CARBETOCIN
UY34200A (en) 3- (FLUOROVINIL) PIRAZOLES AND ITS USE
FR2955770B1 (en) COSMETIC COMPOSITION.
BR112014003027A2 (en) improved herbicidal formulation
TR201903918T4 (en) Compositions containing a dispersing agent and their preparation.
BR112015008524A2 (en) electrolyte formulations for portable oxygen activated heater
UY34314A (en) DERIVATIVES OF ANILINA, ITS PREPARATION AND ITS THERAPEUTIC APPLICATION.
EA201491300A1 (en) COMPOSITION FOR BODY APPLICATION WITH IMPROVED STABILITY
TR201100148A2 (en) Stable acarbose formulations.
UY34829A (en) NEW DOSAGE AND FORMULATION
BR112013023575A2 (en) “octahydrothienoquinoline derivative, pharmaceutical composition comprising the derivative, and use thereof”
PL2908835T3 (en) Stable formulations
TR201100150A2 (en) Water soluble dosage forms
EA201492280A1 (en) STABLE PEXIGANANE COMPOSITION
EA201500313A1 (en) STABILIZED AMORPHOUS FORM OF AGOMELATIN, THE WAY OF ITS MANUFACTURE AND PHARMACEUTICAL COMPOSITIONS, ITS CONTAINING
TR201109158A2 (en) Easily soluble pharmaceutical composition containing eplerenone.